Leprosy Mailing List – November 28, 2020
Ref.: (LML) Replacing opinions about leprosy treatment with research
From: P. Ajit, Maharashtra, India
_________________________________________________________________________
Dear Pieter,
Totally agree with Dr Narsimha Rao Sir's views regarding daily rifampicin (LML, November 23, 2020).
The same thing was always mentioned in leprosy chapter in Harrison textbook by
Dr Robert Gelber. I think since he is on the group he can share his views regarding the same.
Regarding safety, in large number of tuberculosis patients, rifampicin is used on a daily basis and we do have robust safety data.
Thanks,
Dr Ajit.
___________________________________________________________________________
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << edit...@gmail.com
--You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/0ced5064-6847-4da5-abb5-9503cdbaf70bn%40googlegroups.com.
No comments:
Post a Comment